Burning Rock Biotech (BNR) Operating Income (2019 - 2025)

Burning Rock Biotech's Operating Income history runs 7 years deep, the most recent figure standing at -$1.7 million for Q4 2025.

• In Q4 2025, Operating Income rose 84.67% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at -$7.7 million (up 84.46% YoY), while the FY2025 annual figure was -$7.8 million, up 83.99% from the prior year.
• Operating Income was -$1.7 million for Q4 2025 at Burning Rock Biotech, up from -$2.3 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$1.6 million in Q2 2025 to a low of -$41.5 million in Q1 2022.
• Historically, Operating Income has averaged -$21.0 million across 5 years, with a median of -$24.0 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Operating Income slumped 208.49% in 2021, then soared 89.51% in 2025.
• A 5-year view of Operating Income shows it stood at -$39.6 million in 2021, then grew by 20.32% to -$31.5 million in 2022, then advanced by 25.69% to -$23.4 million in 2023, then soared by 52.09% to -$11.2 million in 2024, then soared by 84.67% to -$1.7 million in 2025.
• The last three Operating Income figures came in at -$1.7 million (Q4 2025), -$2.3 million (Q3 2025), and -$1.6 million (Q2 2025), per Business Quant data.